Lilly

Key Takeaways Eli Lilly and Novo Nordisk shares lost ground Thursday, while shares of Viking …

Key Takeaway Eli Lilly announced on its WeChat account Friday that it has won approval …

Key Takeaways Roche announced strong early stage data from its weight-loss drug CT-996. The once-daily …

Key Takeaways American depositary receipts of Novo Nordisk fell Tuesday while shares of Eli Lilly …

Key Takeaways Eli Lilly said it would buy Morphic for roughly $3.2 billion or $57 …

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at …

Key Takeaways Novo Nordisk and Eli Lilly shares lost ground Tuesday after U.S. President Joe …

A sign with the company logo sits outside of the headquarters campus of Eli Lilly …

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York …

Key Takeaways Eli Lilly is partnering with ChatGPT maker OpenAI to use artificial intelligence to …

Key Takeaways ResMed shares fell sharply in intraday trading Monday following the release of clinical …

Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for …

A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at …

Key Takeaways Eli Lilly shares rose in extended-hours trading on Monday after a panel of …